Ever fancied a clear smooth coffee with all the flavour and none of the bitterness? This is what Richard Ayoade, presenter of Channel 4’s, the Gadget Man, wanted in his restaurant of the future.
Heidolph-UK was able to achieve this using the Hei-VAP rotary evaporator which featured in Series 3 Episode 7 about Cooking and Dining Out. Finding new ways of enhancing familiar flavours and even creating new flavours is at the heart of great cooking and is the reason why rotary evaporators are found not only in laboratories but also in the kitchens of Michelin-starred restaurants. Operating at a very low atmospheric pressure, the...
Sophia Genetics, the European leader in Clinical Genomics and Next Generation Sequencing (NGS) data analysis, today launches a unique CFTR IVD Solution allowing clinicians to run full cystic fibrosis analysis in a single NGS experiment.
The CE-IVD marked solution covers the identification and characterisation of all types of variants in a single NGS experiment with clinical grade analytical performance. Until now, it has not been possible to simultaneously analyse all relevant CFTR variants in a one-step NGS experiment. But Sophia Genetics has made two major breakthroughs, which enable the Sophia Data Driven Medicine (DDM) platform to identify and characterise all types of...
Horizon Discovery Group plc, a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced it has entered a worldwide co-exclusive distribution agreement with Haplogen Genomics GmbH (Haplogen).
The agreement provides Horizon with access to a new high-throughput, affordable cell line engineering service. Haplogen’s extensive experience with haploid cell lines, along with a highly optimized production pipeline, allows knockouts for any non-essential gene to be generated at a throughput of hundreds of new isogenic cell lines per month. This highly efficient operation for the first time puts custom and validated human isogenic cell line pairs in...
Leading research and advisory firm, BioInformatics LLC, today announced that 50 companies have met the criteria for nomination as a potential recipient of the prestigious Life Science Industry Awards®.
Over 1,000 scientific customers named more than 400 individual life science companies as “best-in-class” in 30 different award categories. Only 50, however, met the criteria for inclusion as a nominee on the ballot ballot now being completed by thousands of scientists around the world. Their votes will determine the Winners to be named at a gala ceremony to be held at the Grand Hyatt in Washington, DC on November 18, 2014...
Advanced Cell Diagnostics, Inc. (ACD), a global technology and market leader in in situ nucleic acid detection for life science research and clinical diagnostics, has been awarded a two-year, $1.4 million grant from National Cancer Institute (NCI) under its SBIR Phase II Program.
ACD and its academic partner Cleveland Clinic will use the grant to develop and validate a diagnostic test based on ACD’s proprietary RNAscope® technology for discriminating various B-cell non-Hodgkin lymphomas (NHLs) from benign lymphoproliferative diseases. “This award is a further validation of the clinical utility of RNAscope technology. We are very pleased that NCI has recognized the diagnostic potential of...
Scientists have developed a faster method of producing an effective vaccine for the devastating animal disease caused by Bluetongue virus (BTV); a virus that has infected and killed thousands of livestock throughout the world.
BTV is spread to cattle, sheep and some other wild ruminants by a type of midge, which is a biting insect. Infected animals experience a range of symptoms, which are fatal in some cases. There are also indirect impacts including weight loss and reduced milk production. Previous prevention measures have included the culling of animals along with the use of inactivated vaccines...
The line-up for the Lions’ Lair competition at Lab Innovations 2014 has finally been unveiled.
Metrohm, Asynt, Spex Certiprep and the current reigning champions, Cleaver Scientific, will all step into the Lair, pitching their latest technologies and innovations to an expert panel of judges, in front of a live audience, in order to win best in show. First into the Lair will be Cleaver Scientific, with its new product, the COMPAC-50 High Throughput COMET Assay system. Comet Assay has become an increasingly popular procedure for assessing DNA damage...
TAP Biosystems, a leading supplier of innovative cell culture and fermentation systems for life science applications, is delighted to announce that TAP Biosystems and Merck have been nominated as co-finalists for two awards at the prestigious 2014 BioProcess International (BPI) Awards.
The nominations recognise that the ambr250™ System, developed as a result of the collaboration, is a major advance in bioprocessing technology. At the BioProcess International Awards, TAP Biosystems and Merck have been selected as finalists in the ‘Best Collaboration Award’ and the ‘Best Technology Application — Upstream Award’ categories from amongst numerous outstanding industrial collaborations for their partnership to develop the...
Porvair Sciences, a world leader in applications optimised microplates and microplate equipment has appointed SPEware Corporation as its exclusive partner for supporting and servicing its UltraVap, MiniVap and UltraVap Mistral microplate sample concentration systems.
Steve Knight, Sales & Marketing Director at Porvair Sciences commented "We have seen US demand for affordable 96-well and 384-well microplate sample concentration systems grow considerably over the last few years. To enhance local informed support to this rapidly growing community of US customers we have turned to our well established US distribution partner - SPEware Corporation". He added "SPEware Corporation brings over 20-years’ experience of sample...
Agreement brings together expertise to design, develop and market small molecule libraries targeting ubiquitin system proteins.
Ubiquigent Limited, a company specialising in ubiquitin cell-signalling system drug discovery capabilities and services, and the Drug Discovery Unit (the DDU) of the University of Dundee, announced today they have entered into a collaboration agreement to develop and market new ubiquitin system targeted compound libraries aimed at discovering potent and selective therapeutics across multiple areas including; cancer, cardiovascular and metabolic...
Lyonbiopole announces that the French Health authority (ANSM) delivered to Accinov, its Innovation Centre, the authorization to open a pharmaceutical site.
This authorization will allow Accinov to support the companies hosted in the Centre for the production of biological drugs for clinical trials in particular with the pharmaceutical responsibility of Accinov. On September 11th, the French Health authority (ANSM) delivered to Accinov the authorization to open a pharmaceutical site in its facilities located in Lyon-Gerland Biodistrict. This authorization followed an application submitted by Accinov to the...
Cherwell Secures UK Distribution Agreement with Mar Cor for Cleanroom Decontamination Products.
The importance of efficient, reliable decontamination of cleanrooms and other critical areas within the healthcare, pharmaceutical and biotech industries is undeniable. Having signed a UK distribution agreement with Mar Cor Purification, Cherwell Laboratories can now offer a range of dry fog technology and cold sterilant products to...
Agreement covers development of molecular reference standards for companion diagnostics.
Horizon Discovery Group plc (LSE: HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announces that its business unit Horizon Diagnostics has signed a Master Services Agreement with a major global diagnostic development company and a US biopharmaceutical company to support the development of companion diagnostics for novel, genetically-targeted...
Cepheid’s GeneXpert® Infinity System lies at the heart of an innovative, award-winning sexual health screening service in Soho, London. Dean Street Express – run by the Chelsea and Westminster Hospital NHS Foundation Trust – was recently declared the winner of the prestigious Health Service Journal ‘Value in Healthcare Award.
The recently launched CellSep Advanced kit, for use in combination with the Arrow™ Instrument for the automated isolation of up to three cell types directly from whole blood or buffy coat1, was among the new developments revealed to distributors at the Annual DiaSorin Molecular Distributor Meeting held in Bandol, South of France.
As demand for more automated methods for molecular diagnostics and research increases, DiaSorin aims to ensure that its distributors are equipped to meet the evolving needs of customers. The distributors received a range of support materials to help inform and train scientists interested in using CellSep Advanced, including animated films on the use of the Arrow™ Instrument, product literature, and an Application Note from the...
Lab Innovations, the UK’s only show dedicated to the latest laboratory technology and consumables, analytics and biotech equipment, returns to the Birmingham NEC on 5 & 6 November 2014.
This year’s show boasts its strongest ever exhibitor line up, with many using Lab Innovations to launch new technologies and concepts to the UK market. It also features a packed educational programme, with headline speakers Robin Ince, Quentin Cooper and Andrea Sella topping the bill.
Read MoreATCC Announces New Appointments to its Leadership TeamOct 21, 2014
ATCC increases focus on scientific reproducibility and leverages technological advances with new senior executive appointments
ATCC, the premier global biological materials resource and standards organization, is pleased to announce two important appointments to the senior leadership team. Barbie Bigelow has joined ATCC as Executive Vice President of Strategy and Technology and Dr. Maryellen de Mars also joins as the Senior Director for the Standards Resource Center. Both roles are new positions at ATCC. Dr. Raymond H. Cypess, President and CEO at...
greenovation Biotech GmbH and BIOMEVA GmbH announced today the successful production of the world's first GMP (Good Manufacturing Practice)-compliant batch of drug substance manufactured in moss for clinical use.
The drug substance, greenovation's pilot candidate Moss-aGal (recombinant human alpha-galactosidase), is planned to be used for clinical testing as a new generation of enzyme replacement therapy in patients with Fabry disease in the near term. Based on broad experience in the production of proteins for preclinical testing, this production technology has been raised to the next level of successful GMP-manufacturing. The manufacturing of...
GENALICE and Knome, Inc. jointly announced that the Swiss Foundation for People with Rare Diseases has chosen to use their solutions in tandem to improve the Foundation’s processing and analysis of their Next-Generation Sequencing (NGS) data.
GENALICE MAP is an ultra-fast and highly accurate NGS data preprocessing solution and will be connected to Knome’s informatics and genomics interpretation system, the knoSYS® platform. “In the era of high volume NGS data production, a streamlined and affordable pipeline for data processing and analysis is key,” explains Gabor Matyas from the Foundation. “The combination of the solutions of GENALICE and Knome allows our work to...
Horizon Discovery Group plc has agreed to acquire Sage Labs Inc. for up to $16M (£9.8M) in cash and up to $32M (£19.6M) through the issue of new ordinary shares.
The acquisition of Sage, a world leader in the generation of advanced in vivo transgenic disease models for use in preclinical research, builds upon the acquisition of CombinatoRx in July and makes Horizon the world’s leading gene-editing company and the go-to company for the provision of integrated product, service and research solutions at all stages of translational genomics and personalized medicine research from sequence to treatment...
Use of Picsara will provide a more streamlined and secure approach to the patient journey.
HCA International, providers of world class private hospital care, are to collaborate with Swedish-based medical imaging specialists Mawell to transform the delivery of frontline care, enhance their service to patients and improve clinical safety and security. Launching across all HCA International’s clinical UK sites early next year Picsara, a unique multidisciplinary imaging software solution, will enable medical staff across various specialities to capture, store, distribute, analyse, annotate and measure all non-radiology medical images and videos efficiently and securely to help...